Select Page

Fiorella Belpoggi PhD Ramazzini Institute “Carcinogenic effect of base station environmental emissions – the latest results of in vivo studies”

Nov 21, 2018


Fiorella Belpoggi PhD Lecture “Carcinogenic effect of base station environmental emission? the latest results of in vivo studies”

3rd International Forum of Protection from Electromagnetic Environmental Pollution

Krakow, Poland 2018

Dr. Belpoggi shares the findings of evidence of cancer (brain and heart data only) from the large-scale Ramazzini rat studies on radio frequency radiation that were confirmed by NIH pathology review. The malignant schwannomas of the heart  found elevated in the Ramazzini Institute study  are the same tumors as found elevated in the National Toxicology Institute NTP) study. She pointed out that most of the tumors in the Ramazzini Study were found in the last part of their life and after the time period that the NTP sacrificed their animals and this raises questions as to the amount of cancers that might have been found if the NTP study had let the animals live until natural death.

In her lecture she also presented the latest findings from preliminary reports on the newest studies (still unpublished)  of radio frequency in combination with gamma radiation that have found decrease in fertility index, lower litter weights and increased in mammillary tumors (unknown if it is benign or malignant.) This research is ongoing.

Belpoggi et al. 2018, “Report of final results regarding brain and heart tumors in Sprague-Dawley rats exposed from prenatal life until natural death to mobile phone radiofrequency field representative of a 1.8 GHz base station environmental emission” Environmental Research Journal

  • Researchers with the renowned Ramazzini Institute (RI) in Italy performed a large-scale lifetime study of lab animals exposed to environmental levels (comparable to allowable limits from cell towers) of RFR radiation and found the rats developed increased cancers- schwannoma of the heart in male rats. This study confirms the $25 million US National Toxicology Program study which used much higher levels of cell phone radiofrequency (RF) radiation, but also reported finding the same unusual cancers as the Ramazzini- schwannoma of the heart in male rats. In addition, the RI study of cell tower radiation also found increases in malignant brain (glial) tumors in female rats and precancerous conditions including Schwann cells hyperplasia in both male and female rats.
  • “Our findings of cancerous tumors in rats exposed to environmental levels of RF are consistent with and reinforce the results of the US NTP studies on cell phone radiation, as both reported increases in the same types of tumors of the brain and heart in Sprague-Dawley rats. Together, these studies provide sufficient evidence to call for the International Agency for Research on Cancer (IARC) to re-evaluate and re-classify their conclusions regarding the carcinogenic potential of RFR in humans,” said Fiorella Belpoggi PhD, study author and RI Director of Research.
  • The Ramazzini study exposed 2448 Sprague-Dawley rats from prenatal life until their natural death to “environmental” cell tower radiation for 19 hours per day (1.8 GHz GSM radiofrequency radiation (RFR) of 5, 25 and 50 V/m). RI exposures mimicked base station emissions like those from cell tower antennas, and exposure levels were far less than those used in the NTP studies of cell phone radiation.

Belpoggi Fiorella, PhD, FIATP

Fiorella Belpoggi is the Head of Research at the Ramazzini Institute and Director of the Cesare Mal-toni Cancer Research Centre, where she has worked since 1981. Under her leadership, since 2010 the Ramazzini Institute has also launched and managed a GLP laboratory for in vivo studies on rats and mice, performed for the purpose of registration in accordance with European REACH legislation. Dr. Belpoggi?s research interests include short – and long-term toxicity studies on chemicals and physical agents including food additives, solvents, packaging plastics, pesticides, hormones and prescription drugs, vitamins, fuels constituents and additives, endocrine disruptors, asbestos and its substitutes, herbs, gamma radiation, electromagnetic fields from power lines (ELFEMF), and radio base stations (RFR/MW).
Dr. Belpoggi earned a degree in Biological Sciences from the University of Bologna, Italy in 1975 focusing on comparative anatomy and physiology; she then completed a three-year postgraduate training at the Institute of Human Pathological Anatomy and Histology of the Faculty of Medicine of the University of Bologna (1976-1981). As a Visiting Scientist she conducted post-doctoral studies on the classification of human lymphomas/leukemias at the Pathology Institute of Kiel, Germany (1980), and on the relation between cervical cancer and papilloma virus in women at the International Agency for Research on Cancer in Lyon, France (1987) .

In 1992 she was nominated as a Fellow of the Collegium Ramazzini and currently serves as a member of the Executive Council. Dr. Belpoggi has authored more than 100 publications and is an Invited Lecturer of Industrial and Environmental Carcinogenesis at various schools of public health and uni-versities in Italy. She represented the Ramazzini Institute on the Faculty Council of Veterinary Sci-ences at the University of Padova and manages the Institute?s institutional relationship with European agencies and the United States? National Toxicology Program.

Dr. Belpoggi was the 2007 recipient of the Ramazzini Award, conferred each year to scientists deemed by the Collegium Ramazzini to have made outstanding contributions to furthering the aims of Bernardino Ramazzini in safeguarding public health. Dr. Belpoggi has been recognized by several organizations in Italy her work in defense of the environmental and occupational health. She became a Fellow of the International Academy of Toxicologic Pathology in 2011. She is also a member of the European Society of Toxicologic Pathology (ESTP) and of the Society of Toxicologic Pathology (STP). She has been invited as an expert participant to meetings on the evaluation and safety of chemicals at the European Parliament, at the Directorate General for Health and Consumer Affairs (DG SANCO) and at the European Food Safety Agency (EFSA) and as a temporary advisor to the World Health Organization/European Centre for Environment and Health (WHO/ECEH ). She has also served as expert witness for legal cases concerning environmental and occupational diseases, in both Europe and North America.